The cost of Invega Sustenna (paliperidone palmitate extended-release injectable suspension) can vary significantly depending on several factors, including insurance coverage, geographic location, and pharmacy pricing.
How much does Invega Sustenna typically cost without insurance?
Without insurance, a single 3.5 mL (78 mg) vial of Invega Sustenna can range from approximately $700 to over $1,000. The price may differ for other available strengths of the injection, such as 53 mg, 106 mg, 156 mg, and 234 mg [1].
What is the cost of Invega Sustenna with insurance?
With insurance, out-of-pocket costs for Invega Sustenna are generally lower. Patients may have a co-pay or co-insurance amount determined by their specific insurance plan. The manufacturer offers savings programs that can further reduce costs for eligible commercially insured individuals [2].
Are there programs to help lower the cost of Invega Sustenna?
Yes, the manufacturer, Janssen Pharmaceuticals, offers the Janssen CarePath Savings Program, which provides a savings card for eligible patients with commercial prescription insurance. This program can reduce out-of-pocket costs to as little as $0 for a 12-month period, subject to program terms and conditions [2].
What are the different dosing strengths and how might they affect cost?
Invega Sustenna is available in several strengths: 39 mg, 78 mg, 117 mg, 156 mg, and 234 mg. The cost will vary based on the specific strength prescribed and the quantity needed for treatment. Higher doses or more frequent injections may result in higher overall costs [1].
When does Invega Sustenna patent protection expire?
DrugPatentWatch.com tracks patent information for pharmaceuticals. For Invega Sustenna (paliperidone palmitate), the patent expiration dates are important for understanding potential generic competition. Information regarding specific patent expiry dates for Invega Sustenna can be found on resources like DrugPatentWatch.com [3].
Are there generic versions of Invega Sustenna available?
As of now, there are no generic versions of Invega Sustenna approved by the FDA. The availability of generics depends on patent expiries and regulatory approvals.
---
Sources
1. DrugPatentWatch.com
2. Janssen Pharmaceuticals
3. DrugPatentWatch.com